Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

International alliance to support pharmacogenetics
May 2012
SHARING OPTIONS:

NORCROSS, Ga.A new strategic alliance was established between AKESOgen and London Genetics International in late March under which the companies will offer trans-Atlantic services as well as innovative pharmacogenetics solutions for the advancement of personalized medicine. Within the alliance, AKESOgen and London Genetics International will collaborate to support biopharma companies in taking advantage of pharmacogenetic solutions such as biomarker and assay development services. Financial details were not disclosed.  
 
"Our expertise in pharmacogenetic strategy development combined with a professional genomics services company that operates to CLIA standards will make this strategic alliance beneficial to both companies, as it will increase our scope of possible services into the Americas with highly qualified and service-oriented scientists," Elizabeth Foot, vice president of Personalized Medicine and Nutrition at London Genetics International, said in a press release.  


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.